Health hazard evaluation report: HETA-82-207-1278, Garden City Engraving, Augusta, Georgia.
Authors
Salisbury SA
Source
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HETA 82-207-1278, 1983 Mar; :1-14
In response to a management request, an evaluation was conducted of exposures to printing ink vapors at the Garden City Engraving Company (SIC-2751), Augusta, Georgia. The evaluation was requested after all ten employees complained of irritative and respiratory symptoms following a move of the screen printing operations into the main office building. The industrial hygiene survey included employee interviews, assessment of building ventilation, and measurement of airborne levels of toluene (108883), 2-ethoxyethyl- acetate (111159) (2EA), 2-butoxyethanol-acetate (112072) (2BA), diacetone-alcohol (123422) (DA), isophorone (75581), and a solvent consisting of a mixture of aromatic petroleum hydrocarbons. The primary organic vapors detected in bulk air samples were 2EA, DA, toluene, isophorone, 2BA, and a mixture of alkyl substituted benzenes. Results of personal and area air samples did not indicate exposures in excess of OSHA permissible limits; however, 2EA levels were in excess of the most recent threshold limit value (5 parts per million) recommended by the American Conference of Governmental Industrial Hygienists. Improper local exhaust ventilation was noted in the printing department. Five of the eight employees interviewed reported work related symptoms. The author concludes that airborne concentrations of ink vapors were below levels expected to cause adverse health effects. The author recommends that efforts be made to improve ventilation and reduce worker exposures.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.